阿育吠陀药物在2型糖尿病管理中的有效性和安全性：一项系统评价方案

Effectiveness and safety of Ayurvedic medicines in type 2 diabetes mellitus management: a systematic review protocol.

作者信息

Chattopadhyay Kaushik, Panniyammakal Jeemon, Biswas Tuhin Kanti, Heinrich Michael, Lewis Sarah Anne, Greenfield Sheila Margaret, Tandon Nikhil, Kinra Sanjay, Leonardi-Bee Jo

机构信息

Division of Epidemiology and Public Health, School of Medicine, University of Nottingham, Nottingham, United Kingdom.

The Nottingham Centre for Evidence-Based Healthcare: A JBI Centre of Excellence, Nottingham, United Kingdom.

出版信息

JBI Evid Synth. 2020 Nov;18(11):2380-2389. doi: 10.11124/JBISRIR-D-19-00350.

DOI:10.11124/JBISRIR-D-19-00350

PMID:32813403

Abstract

OBJECTIVE

The objective of this review is to evaluate and synthesize evidence on the effectiveness and safety of Ayurvedic medicines for managing type 2 diabetes mellitus.

INTRODUCTION

Several randomized controlled trials have been conducted to assess the effectiveness and safety of Ayurvedic medicines for managing type 2 diabetes. Systematic reviews have been conducted on this topic but need to be updated. The findings from this review will be used to develop a clinical guideline for managing type 2 diabetes by Ayurvedic practitioners in India.

INCLUSION CRITERIA

Randomized controlled trials assessing the effectiveness and safety of Ayurvedic medicines for managing type 2 diabetes in adults will be included in this systematic review.

METHODS

The authors will search for a wide range of sources to find both published and unpublished studies, including, but not limited to, MEDLINE (Ovid), Embase (Ovid), CINAHL (EBSCOhost), PsycINFO (Ovid), Web of Science, Cochrane Central Register of Controlled Trials (CENTRAL), and Allied and Complementary Medicine Database (Ovid). No language restrictions will be applied. The JBI systematic review methodology will be followed when conducting the review. Data synthesis will be conducted using narrative synthesis and meta-analyses, where appropriate.

SYSTEMATIC REVIEW REGISTRATION NUMBER

PROSPERO CRD42018118285.

摘要

目的

本综述的目的是评估和综合有关阿育吠陀药物治疗2型糖尿病有效性和安全性的证据。

引言

已经进行了多项随机对照试验来评估阿育吠陀药物治疗2型糖尿病的有效性和安全性。关于这个主题已经进行了系统综述，但需要更新。本综述的结果将用于为印度的阿育吠陀从业者制定2型糖尿病管理的临床指南。

纳入标准

评估阿育吠陀药物治疗成人2型糖尿病有效性和安全性的随机对照试验将纳入本系统综述。

方法

作者将搜索广泛的来源以查找已发表和未发表的研究，包括但不限于MEDLINE（Ovid）、Embase（Ovid）、CINAHL（EBSCOhost）、PsycINFO（Ovid）、科学引文索引、Cochrane对照试验中心注册库（CENTRAL）以及综合与补充医学数据库（Ovid）。不设语言限制。进行综述时将遵循JBI系统综述方法。将酌情使用叙述性综合和荟萃分析进行数据综合。